Is Embody Tirzepatide FDA Approved? The Answer, Plus How Dosing Works

By WPG Research Team · Last verified November 2, 2026

No. Embody's tirzepatide is compounded and not FDA-approved, and the FDA does not review it for safety, effectiveness or quality. The FDA-approved tirzepatide brands are Zepbound (weight loss) and Mounjaro (type 2 diabetes). Embody's clinician sets your dose, and the price stays the same at any dose: $129 for one month, or $99 a month on a prepaid year.

Weight Loss Provider Guide is an independent comparison resource for GLP-1 telehealth providers. Below, we show how Embody's dosing works, what each dose costs next to brand-name Zepbound, and the catch with that $99 price.

• Bottom line: Embody is a fair pick if you're fine with compounded medicine and want one flat price while your dose goes up.
• Best for: cash payers who want tirzepatide at one price, even as the dose goes up.
• Not best for: anyone who wants an FDA-approved medicine or wants to use insurance. Ro is the better fit there.
• The factor that matters most: whether you're okay with a medicine the FDA hasn't reviewed.

Already okay with compounded medicine and want a price that won't climb with your dose?

See Embody's tirzepatide plans

No. Embody's tirzepatide is made by a compounding pharmacy for each patient's prescription. The FDA says compounded drugs are not FDA-approved, and it does not check their safety, effectiveness or quality before they're sold. Embody says the same thing on its own site.

Here's the plain version. "Compounded" means a licensed pharmacy mixes the medicine for you instead of a drug company making it in a factory under an FDA approval. Tirzepatide is the active ingredient. But only Eli Lilly's finished products, Zepbound and Mounjaro, went through the FDA's review.

What Embody says on its homepage, word for word: "Compounded medications have not been evaluated or approved by the FDA for safety, efficacy, or quality." Its footer also says compounded GLP-1s "are produced in FDA-regulated facilities." That line is about the building, not the medicine. A regulated pharmacy can still make a drug that isn't FDA-approved, and Embody's footer says that too.

A 503A pharmacy is a state-licensed pharmacy that compounds medicine for one patient's prescription at a time. Embody says its partner pharmacies are 503A pharmacies, and it names four: Red Rock Compounding Pharmacy, Health Warehouse, Precision Medicine and Triad Rx. For each pharmacy's record, see What pharmacy does Embody use?

One thing to watch for anywhere you shop: the FDA lists "claims such as the compounded drug is the same as an FDA-approved drug" as a red flag. Compounded tirzepatide is not a generic Zepbound. It's a different product.

Is compounded tirzepatide still legal in 2026?

Yes, under narrow rules. A 503A pharmacy can compound for an individual patient with a valid prescription. What changed is the shortage. The FDA declared the tirzepatide shortage over on December 19, 2024, and its grace period for 503A pharmacies ended February 18, 2025. Since then, pharmacies can't regularly make copies of a drug that's available.

On April 30, 2026, the FDA proposed keeping tirzepatide off the list of ingredients that larger 503B outsourcing facilities may compound from. As of November 2, 2026, we found no final decision in the Federal Register. That proposal is about 503B facilities. Embody says it uses 503A pharmacies.

Not the medicines in its catalog. On November 2, 2026, Embody's store listed compounded semaglutide and compounded tirzepatide shots. Both are compounded, so neither is FDA-approved. We didn't see brand-name Zepbound, Mounjaro or Wegovy for sale in its catalog.

Embody itself is a telehealth company, and the FDA doesn't approve companies. Embody says medical care is provided by OpenLoop Health. If you want an FDA-approved GLP-1, see Is Ro GLP-1 FDA approved? or our list of the cheapest FDA-approved GLP-1 options.

Not sure which way to go? The right GLP-1 path isn't the same for everyone. It depends on your state, your insurance, your budget, whether you want FDA-approved or compounded, and whether you want a shot or a pill. Our free tool sorts that out before you pick.

See which GLP-1 path fits you

Embody doesn't publish a fixed dosing schedule. Its clinician picks your starting dose and raises it over time "as clinically appropriate," based on how you respond. Embody says it offers "multiple dosing options based on your provider's recommendation."

What that means in practice:

• New to tirzepatide: your clinician sets the starting dose and the pace of each step up.
• Already on a GLP-1 elsewhere: Embody asks for proof of your current prescription. If its clinician agrees, you can keep your current dose.
• Side effects or a plateau: Embody lists "clinician oversight & dose adjustments as needed" in every plan.

This page explains how dosing works. It isn't dosing advice. Your clinician decides your dose, so don't change it on your own.

The FDA label schedule clinicians use as a reference

The schedule below comes from Zepbound's FDA label. Compounded tirzepatide has no FDA label of its own, but this is the approved schedule for the same active ingredient. Mounjaro's label uses the same steps and the same 15 mg maximum.

The label says doses go up in 2.5 mg steps, with at least 4 weeks at each one. Many people stay at 5 mg or 10 mg and never reach 15 mg. The label's maintenance doses are 5, 10 or 15 mg a week. For the full week-by-week chart, see our tirzepatide dosing schedule.

Why this matters with a compounder: the FDA has received reports of side effects, some serious, in people given compounded tirzepatide at doses beyond the label. That means more per shot, shots more often, or stepping up faster. The FDA asks prescribers to be careful with compounded doses. It's fair to ask Embody's clinician how your plan compares with the label.

Units vs. milligrams: the dosing mistake to avoid

Compounded tirzepatide usually comes in a vial, and you draw your dose into a syringe. Your prescription is in milligrams (mg), but the syringe is marked in units. How many units equal your dose depends on how strong your vial is, and that can differ by pharmacy.

The FDA has reports of people being hurt after measuring the wrong amount of compounded GLP-1 medicine. So before your first shot, and again whenever a new vial arrives:

1. Read the strength on the vial label (mg per mL).
2. Ask your clinician or the pharmacy how many units equal your dose in mg.
3. Use a new, sterile needle and syringe for every shot.
4. Throw the vial away 28 days after you first open it, even if medicine is left. That's the FDA's advice for multi-dose vials.
5. Don't use medicine that arrives warm or without enough cold packs.

Taking birth control pills? Zepbound's label says tirzepatide can make birth control pills work less well. It advises switching to a non-pill method, or adding a barrier method, for 4 weeks after you start and for 4 weeks after each dose increase. Embody's own safety page gives the same advice. Ask your clinician about it before each step up.

No. Embody says your price doesn't go up when your dose changes, as long as you stay on the same medicine and plan. What you pay depends only on the plan length you choose. That's different from brand-name Zepbound vials, which cost more at higher doses.

Embody's tirzepatide plans on November 2, 2026:

Embody's FAQ calls these 4-, 12-, 24- and 52-week plans. Its product page shows $129 as a sale price next to a $349 regular price, so check the price for your plan at checkout. For the full math, see our Embody GLP-1 cost breakdown.

What each dose costs: Embody vs. Zepbound vials

This is what the same dose steps cost on Embody's plans and on brand-name Zepbound vials from LillyDirect, Lilly's own pharmacy. These are two different products. Zepbound is FDA-approved; Embody's tirzepatide is compounded.

*LillyDirect's $449 price at 7.5 mg to 15 mg applies when you refill within 45 days. Needles and syringes cost extra. LillyDirect sells the medicine only, so you'd still need a prescriber. Embody's plans include the compounded medicine and visits with its medical team.

A worked example. Say your clinician starts you at 2.5 mg and steps you up every 4 weeks until you reach 10 mg in month four. On Embody's 1-month plan, those four months cost 4 × $129 = $516. The same doses as Zepbound vials from LillyDirect cost $299 + $399 + $449 + $449 = $1,596 for the medicine alone. That gap is the main reason people pick compounded. The trade-off is the FDA review you give up.

The catch with the $99 price

The $99 a month is not a monthly bill. It's the 12-month plan, paid as $1,188 up front. Embody's refund policy says all payments are final. Multi-month plans are "non-refundable in whole and in part." The only exception is if Embody's clinician finds you're not medically eligible. Then Embody refunds the unused part.

That matters with tirzepatide, because nobody knows ahead of time how you'll handle it. If you're new to it, the 1-month plan costs more per month but puts less money at risk. To stop renewals, cancel at least 72 hours before your next billing date, in your portal or by emailing support@joinem.co. Steps are in how to cancel Embody.

Good fit so far? If you're an adult who's fine with compounded medicine, paying cash, and wants one price at every dose, Embody's intake takes a few minutes. Its clinician decides if tirzepatide is right for you.

Check if you qualify with Embody

Then you want Zepbound, or Mounjaro if you have type 2 diabetes. Both are FDA-approved and made by Eli Lilly. You can get Zepbound through Ro, with insurance or cash, or buy the vials from LillyDirect with a prescription.

Ro is our top pick for FDA-approved medicine and insurance help. Prior authorization is a permission slip your insurer may want before it pays. Ro's insurance team handles that paperwork. Ro says you'll know if you're eligible within 2 days. The Zepbound pen can go through insurance, while the KwikPen and vials are cash pay through Ro.

The trade-off is cost. A brand-name medicine plus a membership usually costs more than Embody unless your insurance helps. Compare them side by side in Embody vs Ro.

Have insurance that might cover Zepbound? Ro can check it for you.

Check your Zepbound coverage with Ro

Answer these before you pick a route. They'll tell you if you're likely to qualify and which option fits.

• Are you an adult with obesity, or overweight with a weight-related health problem? That's who Zepbound's label covers. Clinicians at Embody and Ro use their own intake to decide.
• Do you have insurance that covers weight-loss drugs? If yes, check Ro first. Embody doesn't take insurance; see Does Embody take insurance?
• Do you want to pay with an HSA or FSA card? Embody's homepage says "HSA/FSA Approved." More in Embody HSA/FSA.
• Which state do you live in? Embody says its program "may not be available in all states." Its intake checks this.

Safety note: GLP-1 medicines, including tirzepatide, are not right for everyone. Do not use if you or a family member has had medullary thyroid cancer (MTC), or if you have MEN 2. If you're pregnant, planning a pregnancy or breastfeeding, talk with your own doctor first.

Is Embody FDA approved?

Embody is a telehealth company, and the FDA doesn't approve companies. The medicines Embody sells, compounded semaglutide and compounded tirzepatide, are not FDA-approved. Embody says so on its own site.

Is Embody's tirzepatide the same as Zepbound?

No. Both contain tirzepatide, but Zepbound is Eli Lilly's FDA-approved product. Embody's is compounded by a pharmacy and hasn't been through the FDA's review. The FDA warns against any seller claiming a compounded drug is the same as an approved one.

What dose of tirzepatide does Embody start you on?

Embody doesn't publish a fixed starting dose. Its clinician decides based on your health and history. For reference, Zepbound's FDA label starts everyone at 2.5 mg once a week for 4 weeks.

Does Embody charge more for higher doses of tirzepatide?

No. Embody says your price stays the same when your dose changes, as long as you stay on the same medicine and plan. On November 2, 2026, that was $129 for one month or $99 a month on a prepaid 12-month plan.

Can I keep my current tirzepatide dose if I switch to Embody?

Possibly. Embody asks for proof of your current prescription. If its clinician agrees, you can continue at your current dose.

Is compounded tirzepatide safe?

Compounded tirzepatide has not been reviewed by the FDA for safety, effectiveness or quality. As of May 31, 2026, the FDA had received more than 730 reports of side effects tied to compounded tirzepatide. The FDA notes it can't always tell whether the drug itself caused them. The FDA-approved option is Zepbound.

What is the highest dose of tirzepatide?

Zepbound's and Mounjaro's FDA labels set the highest dose at 15 mg once a week. Doses go up in 2.5 mg steps, with at least 4 weeks at each step.

Still not sure which GLP-1 path fits you? Take our free Find My GLP-1 Path quiz — about 2 minutes, no signup.

Find My GLP-1 Path

We do not accept payment for rankings. How we compare providers is in How We Rank. For a full Embody tirzepatide review, see Embody tirzepatide reviews, or compare more programs on Best GLP-1 online programs.

All checked November 2, 2026.

• Embody: homepage and FAQ
• Embody: compounded tirzepatide, one month supply
• Embody: compounded tirzepatide, twelve month supply
• Embody: GLP-1 medication safety information
• Embody: cancellation and refund policy
• Zepbound prescribing information (FDA label)
• Mounjaro prescribing information
• FDA: Compounding and the FDA, questions and answers
• FDA: Concerns with unapproved GLP-1 drugs used for weight loss
• FDA: Policies for compounders as GLP-1 supply stabilizes (tirzepatide shortage resolved)
• FDA: Compounding when drugs are on the drug shortages list
• FDA: Proposal to exclude semaglutide, tirzepatide and liraglutide from the 503B bulks list
• Federal Register: 503B bulks list comment period extension
• Ro: Weight loss and Ro Body membership
• LillyDirect: Zepbound